Cover Image

Establishing meaningful change thresholds for European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire CLL‐specific module domain scores: An analysis based on the TRANSCEND CLL 004 study in patients with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Laurie Eliason, Fatoumata Fofana, Lin Wang, Peter A. Riedell, Shien Guo
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	eJHaem
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A decade of chronic lymphocytic leukaemia therapy in Germany: Real‐world treatment patterns and outcomes (2010–2022)
by: Hannes Wartmann, et al.
Published: (2024)

Uptake of the first to fifth doses of coronavirus disease 2019 vaccine in individuals with chronic lymphocytic leukaemia: A nationwide cohort study in Sweden
by: Pontus Hedberg, et al.
Published: (2025)

Noninvasive prenatal testing in CLL during pregnancy: A cautionary tale
by: Jorn L. J. C. Assmann, et al.
Published: (2025)

Intracytoplasmic inclusions in chronic lymphocytic leukemia cells of an elderly person living with human immunodeficiency virus and presenting with Richter transformation to Hodgkin lymphoma
by: Evashin Pillay, et al.
Published: (2025)

MicroRNAs: Potential prognostic and theranostic biomarkers in chronic lymphocytic leukemia
by: Afgar Ali, et al.
Published: (2024)

Concurrent hyperdiploid acute myeloid leukemia and trisomy 12+ chronic lymphocytic leukemia
by: Tulasi Geevar, et al.
Published: (2024)

The prognostic value of POD24 in relapsed/refractory follicular lymphoma—A SCHOLAR‐5 analysis
by: Eve H. Limbrick‐Oldfield, et al.
Published: (2025)

Monitoring of molecular responses to tirabrutinib in a cohort of exceptional responders with relapsed/refractory mantle cell lymphoma
by: Abdullah N. M. Alqahtani, et al.
Published: (2024)

Lisocabtagene maraleucel for treatment of relapsed and refractory primary mediastinal large B‐cell lymphoma in an adolescent patient
by: Dasom Lee, et al.
Published: (2024)

CD4+ chronic lymphocytic leukemia in an 86‐year‐old male veteran: A case report
by: Sara Abdelrahim, et al.
Published: (2024)

Medical history and lifestyle factors have limited impact on time‐to‐first‐treatment in patients with chronic lymphocytic leukemia
by: Ingrid Glimelius, et al.
Published: (2024)

Real‐world outcomes of patients with relapsed/refractory large B‐cell lymphoma receiving second‐line therapy in England
by: Christopher P. Fox, et al.
Published: (2024)

Early CAR− CD4+ T‐lymphocytes recovery following CAR‐T cell infusion: A worse outcome in diffuse large B cell lymphoma
by: Massimiliano Gambella, et al.
Published: (2024)

Pneumonia in patients with chronic lymphocytic leukemia treated with venetoclax‐based regimens: A real‐world analysis of Polish Adult Leukemia Group (PALG)
by: Elżbieta Kalicińska, et al.
Published: (2024)

Isolated central nervous system relapse in mantle cell lymphoma
by: Radu Chiriac, et al.
Published: (2025)

Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamab
by: Syed Naqvi, et al.
Published: (2024)

Gene expression prognostic of early relapse risk in low‐risk B‐cell acute lymphoblastic leukaemia in children
by: Xiaowen Gong, et al.
Published: (2024)

Carfilzomib use in patients with relapsed/refractory multiple myeloma in France: A national retrospective cohort study
by: Cyrille Hulin, et al.
Published: (2024)

Extramedullary chronic phase chronic myeloid leukaemia (CML) involving the central nervous system: A case report
by: Akshay Deshpande, et al.
Published: (2024)

“Fast but not so furious”: A condensed step‐up dosing schedule of teclistamab for relapsed/refractory multiple myeloma
by: Kevin C. Graf, et al.
Published: (2024)

Effective treatment of relapsed/refractory CD19‐positive B/T‐type mixed‐phenotype acute leukemia with blinatumomab: A case report
by: Masanori Aoki, et al.
Published: (2024)

Sequential treatment with valemetostat and conventional anti‐cancer drugs for refractory aggressive adult T‐cell leukemia/lymphoma: A case report
by: Kosuke Obama, et al.
Published: (2024)

A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B‐cell or T‐cell acute lymphoblastic leukemia: Results from the ECOG‐ACRIN EA9152 protocol
by: Neil D. Palmisiano, et al.
Published: (2024)

Successful treatment of refractory donor‐specific‐human leukocyte antigen‐antibody‐induced primary graft‐failure with daratumumab: A case report
by: Vadim Lesan, et al.
Published: (2024)

Blastic transformation of follicular lymphoma
by: Hayato Mori, et al.
Published: (2024)

When acute promyelocytic leukaemia changes its face in the peripheral blood
by: Sophie Le Grand, et al.
Published: (2024)

Elimination of residual adult T‐cell leukaemia clones by Tax‐targeted dendritic cell vaccine
by: Tadafumi Iino, et al.
Published: (2025)

Terminal deoxynucleotidyl transferase‐positive high‐grade B‐cell lymphoma with MYC and BCL2 rearrangements transformed from follicular lymphoma
by: Radu Chiriac, et al.
Published: (2024)

A phase 1b/2 study evaluating efficacy and safety of MP0250, a designed ankyrin repeat protein (DARPin) simultaneously targeting vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), in combination with bortezomib and dexamethasone, in patients with relapsed or refractory multiple myeloma
by: Stefan Knop, et al.
Published: (2024)

B‐lymphoblastic leukemia/lymphoma with DUX4 rearrangement
by: Wing Kit Lam, et al.
Published: (2024)

Real‐World Insights Into the Clinical Characteristics and Survival Outcomes of Extranodal Peripheral T‐Cell Lymphomas: A Multiethnic Asian Cohort Study
by: Ryan Yee Shien Neo, et al.
Published: (2025)

CD34‐TdT‐B‐ALL masquerading as Burkitt lymphoma
by: Manu Juneja, et al.
Published: (2024)

A phase 2 study of frontline pembrolizumab in follicular lymphoma
by: Carrie Ho, et al.
Published: (2024)

Novel BRAF N581S mutation in mantle cell lymphoma
by: Nisha Hariharan, et al.
Published: (2024)

B‐cell maturation antigen expression and clinical features of plasmablastic lymphoma
by: Ning Dong, et al.
Published: (2024)

Asteatotic eczema, a cutaneous manifestation of Hodgkin lymphoma in older patients
by: Ariane Le Clainche Compagnie, et al.
Published: (2024)

Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors
by: B. Linder Grønvold, et al.
Published: (2024)

Low‐dose nivolumab for extranodal natural killer/T‐cell lymphoma, nasal type
by: Satish Maharaj, et al.
Published: (2024)

Hepatic T cell lymphoma after chimeric antigen receptor T cell therapy for myeloma
by: Joshua Mehr, et al.
Published: (2024)

Association between microenvironment‐related genes and prognosis of primary central nervous system lymphoma
by: Keiichiro Hattori, et al.
Published: (2024)